Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 14, 2024; 30(26): 3198-3200
Published online Jul 14, 2024. doi: 10.3748/wjg.v30.i26.3198
Published online Jul 14, 2024. doi: 10.3748/wjg.v30.i26.3198
Non-participation of asymptomatic candidates in screening protocols reduces early diagnosis and worsens prognosis of colorectal cancer
Sergio Pérez-Holanda, Office of Regional Viceministry of Health, Regional Viceministry of Health, Oviedo 33005, Asturias, Spain
Author contributions: Pérez-Holanda S write and revise the paper.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Sergio Pérez-Holanda, MD, MSc, PhD, Doctor, Senior Scientist, Surgeon, Surgical Oncologist, Office of Regional Viceministry of Health, Regional Viceministry of Health, C Arturo Álvarez Buylla, Oviedo 33005, Asturias, Spain.
Received: March 14, 2024
Revised: May 31, 2024
Accepted: June 18, 2024
Published online: July 14, 2024
Processing time: 117 Days and 1.1 Hours
Revised: May 31, 2024
Accepted: June 18, 2024
Published online: July 14, 2024
Processing time: 117 Days and 1.1 Hours
Core Tip
Core Tip: Agatsuma et al’s study used cancer registries from two Japanese hospitals to identify the subgroups that benefit most from screening programs, and clarified the stage at diagnosis in three groups of colorectal cancer (CRC) patients: CRC screening, follow-up (patients detected during follow-up for other comorbidities), and CRC symptomatic. The proportion of early-stage diagnoses was higher in the follow-up group than in the symptomatic group and was comparable to that in the cancer screening group. Therefore, CRC screening should be recommended, especially in patients without regular hospital visits for comorbidities, to improve population participation.